Milena Fini, M.D. (gender: female, date of birth: 22/10/1962). Degree in Medicine and Surgery (1989), Specialization in Emergency in Surgery with honours (1994) and Specialization in Orthopaedic and Traumatology with honours (2003) – Faculty of Medicine, University of Bologna; II Level Master in “Clinical Governance of Research in healthcare” – University of Modena and Reggio Emilia (2011). She is director of the Laboratory of Preclinical and Surgical Studies (from 2010) and is the Person in Charge of Research and Organization of the Laboratory of Biocompatibility, Technological Innovations and Advanced Therapies – Rizzoli RIT Department (from 2009); Responsible of Animal Welfare and related equipment following Directive 2010/63/EU on the protection of animals used for scientific purposes; Coordinator of the IOR Translational Research Line “Musculoskeletal Regenerative Medicine” – IOR (from 2013). She is involved in preclinical and clinical research projects on regenerative medicine of bone and cartilage, biomaterials, mesenchymal stem cells for the treatment of musculoskeletal diseases (funded from the Italian Ministry of Health, Ministry of Education, Universities and Research, Enterprises, Bank foundations, Emilia Romagna Region). She is editorial Board member of BioMed Res Int; advisory Board member of JAB-FM; Executive Member of SIB, ISMULT, Indo- Italian Forum of Biomaterials and Tissue Engineering; National Delegate Cost Action-MB1301; Expert of Reference Center for Alternative Methods, Welfare and Care of Laboratory Animals, IZSLER. Her main scientific interests include biomaterials, biocompatibility, scaffolds, tissue engineering and regenerative medicine of the musculoskeletal tissues, in vitro advanced models and in vivo preclinical research, osteointegration, osteoporosis, osteoarthritis, tendinopathies, osteolysis, fractures and bone losses, bone metastases, osteomyelitis. She is author of more than 485 publications, with a H-Index of 55 (source: Scopus).